EATONTOWN, N.J., Aug. 24 /PRNewswire-FirstCall/ -- Osteotech, Inc.
(Nasdaq: OSTE) today issued the following statement in response to
questions the Company has received regarding Donor Referral Services as a
result of recent stories in the media.
We want to assure our customers, partners, shareholders, and employees,
that Osteotech does not conduct and has never conducted business with Donor
Referral Services.
Osteotech is committed to upholding the highest ethical standards and
strictest screening processes to ensure the safety of all tissue processed
and released by Osteotech.
Osteotech, Inc., headquartered in Eatontown, New Jersey, is a leading
provider of human bone and bone connective tissue for transplantation and
an innovator in the development and marketing of biomaterial and implant
products for musculoskeletal surgery. For further information regarding
Osteotech or this press release, please go to Osteotech's website homepage
at http://www.osteotech.com and to Osteotech's Financial Information
Request Form website page at http://www.osteotech.com/finrequest.htm.
SOURCE Osteotech, Inc.
 back to top
Related links:
http://www.osteotech.com
http://www.prnewswire.com/comp/668050.html /
CONTACT:
Mark Burroughs of Osteotech, Inc.,
+1-732-542-2800
|
